Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
2(9%)
Results Posted
0%(0 trials)
Terminated
2(9%)

Phase Distribution

Ph phase_3
1
4%
Ph phase_4
1
4%
Ph phase_2
1
4%
Ph not_applicable
16
70%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution19 total trials
Phase 2Efficacy & side effects
1(5.3%)
Phase 3Large-scale testing
1(5.3%)
Phase 4Post-market surveillance
1(5.3%)
N/ANon-phased studies
16(84.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

9 of 12 finished

Non-Completion Rate

25.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

23

all time

Status Distribution
Active(2)
Completed(9)
Terminated(3)
Other(9)

Detailed Status

unknown9
Completed9
Terminated2
Active, not recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
2
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (5.3%)
Phase 31 (5.3%)
Phase 41 (5.3%)
N/A16 (84.2%)

Trials by Status

withdrawn14%
terminated29%
unknown939%
active_not_recruiting29%
completed939%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT04342832Not Applicable

Cryoballoon Ablation Versus Medical Therapy in Patients With Heart Failure and Atrial Fibrillation

Terminated
NCT03847636Not Applicable

CryoBalloon Ablation for Treatment of Duodenal Adenomas

Active Not Recruiting
NCT05507749Not Applicable

Cyroablation for Pulmonary Vein Isolation Alone in Patients with Early Persistent AF Assessed by Continuous Monitoring

Active Not Recruiting
NCT04942834Not Applicable

Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation

Unknown
NCT04269785Not Applicable

Inflammatory and Endothelial Function Response, and Arrhythmia Recurrence Following Catheter Ablation for Atrial Fibrillation

Withdrawn
NCT05364866

CAB Versus Medical Therapy in Patients With AF and HF With Different EF Categories

Unknown
NCT05492760

Evaluation of Recurrence Risk of Atrial Fibrillation After Cryoballoon Ablation

Unknown
NCT01293448Not Applicable

Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium

Completed
NCT03636100

Release of Acetylcholine From the Ganglionated Plexus During the Thaw Phase of Cryoballon Pulmonary Vein Ablation (GP RESPONSE Study)

Terminated
NCT03805555Not Applicable

Radiofrequency vs Cryoballoon Ablation for Atrial Fibrillation Assessed by Implantable Cardiac Monitor

Completed
NCT03700307Not Applicable

Effects of Different Surgical Methods for Persistent Atrial Fibrillation Combined With the Application of Statin Drugs on Left Atrial Function

Completed
NCT03811639Not Applicable

Changes in Cardiac Autonomic Nervous System Following Atrial Fibrillation Ablation.

Completed
NCT03443232Not Applicable

Effect of Catheter Ablation on Left Atrial Function in Persistent Atrial Fibrillation

Completed
NCT02074566Not Applicable

Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: The 1-2-3 Study

Completed
NCT03564925Not Applicable

Wide Area Circumferential Ablation With Contact Force Versus Cryoballoon Ablation

Unknown
NCT03573869Not Applicable

Atrial FIbrillation Treatment With Cryoballoon in Heart failurE (AFICHE)

Unknown
NCT03365700Not Applicable

Cryoballon Versus Radiofrequency Ablation for Persistent Atrial Fibrillation

Unknown
NCT03044951Not Applicable

Comparison of RF and crYoballoon ablatiOn Therapy of AF(CRYO-AF)

Unknown
NCT01563848Phase 2

Cryoablation in Patients With Atrial Flutter

Unknown
NCT02166723

Persistent Atrial Fibrillation Cryoballoon Ablation

Unknown

Drug Details

Intervention Type
PROCEDURE
Total Trials
23